DarioHealth Corp. (DRIO) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 12.21M USD | Gross Profit |
| Revenue | (m) | |
| Cost of products and services | 8.79M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $12.21M | (m) | $8.79M | (m) |
| 2026-03-31 | $11.98M | (m) | $9.21M | (m) |
| 2025-12-31 | $12.66M | (m) | $9.69M | (m) |
| 2025-09-30 | $14.06M | (m) | $10.67M | (m) |
| 2025-06-30 | $14.93M | (m) | $12.22M | (m) |
| 2025-03-31 | $14.72M | (m) | $13.32M | (m) |
| 2024-12-31 | $13.27M | (m) | $13.77M | (m) |
| 2024-09-30 | $9.20M | (m) | $13.86M | (m) |
| 2024-06-30 | $5.93M | (m) | $13.22M | (m) |
| 2024-03-31 | $5.25M | (m) | $13.80M | (m) |
| 2023-12-31 | $5.98M | (m) | $14.37M | (m) |
| 2023-09-30 | $8.58M | (m) | $14.96M | (m) |
| 2023-06-30 | $9.77M | (m) | $16.86M | (m) |
| 2023-03-31 | $8.84M | (m) | $17.82M | (m) |
| 2022-12-31 | $9.65M | (m) | $18.00M | (m) |
| 2022-09-30 | $7.47M | (m) | $15.30M | (m) |
| 2022-06-30 | $6.50M | (m) | $14.37M | (m) |
| 2022-03-31 | $6.87M | (m) | $13.60M | (m) |
| 2021-12-31 | $3.96M | (m) | $12.44M | (m) |
| 2021-09-30 | $3.96M | (m) | $9.28M | (m) |
| 2021-06-30 | $3.69M | (m) | $7.67M | (m) |
| 2021-03-31 | $2.81M | (m) | $6.16M | (m) |
| 2020-12-31 | $2.51M | (m) | $5.06M | (m) |
| 2020-09-30 | $2.80M | (m) | $4.49M | (m) |
| 2020-06-30 | $3.13M | (m) | $3.99M | (m) |
| 2020-03-31 | $2.82M | (m) | $4.17M | (m) |
| 2019-12-31 | $2.60M | (m) | $4.96M | (m) |
| 2019-09-30 | $1.98M | (m) | $5.48M | (m) |
| 2019-06-30 | $1.57M | $7.47M | $5.90M | 21.08% |
| 2019-03-31 | $1.77M | $7.88M | $6.11M | 22.47% |
| 2018-12-31 | $1.76M | $7.39M | $5.63M | 23.87% |
| 2018-09-30 | $2.11M | $7.27M | (m) | 29.03% |
| 2018-06-30 | $1.92M | $6.77M | (m) | 28.35% |
| 2018-03-31 | $1.76M | $5.92M | (m) | 29.68% |
| 2017-12-31 | $1.31M | $5.17M | (m) | 25.36% |
| 2017-09-30 | $95.00K | $4.43M | (m) | 2.14% |
| 2017-06-30 | $-105.00K | $3.78M | (m) | -2.78% |
| 2017-03-31 | $-622.00K | $3.24M | (m) | -19.19% |
| 2016-12-31 | $-830.00K | $2.80M | (m) | -29.61% |
| 2016-09-30 | $-442.00K | $2.27M | (m) | -19.45% |
| 2016-06-30 | $-649.00K | $1.82M | (m) | -35.70% |
| 2016-03-31 | $-727.00K | $1.32M | (m) | -54.91% |
| 2015-12-31 | $-855.00K | $823.00K | (m) | -103.89% |
| 2015-09-30 | $-1.70M | $566.00K | (m) | -299.82% |
| 2015-06-30 | $-2.15M | $293.00K | (m) | -734.13% |
| 2015-03-31 | $-2.52M | $118.00K | (m) | -2136.44% |
| 2014-12-31 | $-2.71M | $51.00K | (m) | -5317.65% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $0.00 | $0.00 | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |